Ryvu Therapeutics.
zł17.08
9
+zł0.10+0.59% 15:00 Today
Statistics
Day High
17.1
Day Low
16.7
52W High
31.9
52W Low
13.64
Volume
11,524
Avg. Volume
41,874
Mkt Cap
394.89M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
21MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Financials
-162.61%Profit Margin
Unprofitable62.25MRevenue
-101.23MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RVU.WA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Ryvu Therapeutics S.A. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing novel small molecule treatments for oncology. Their primary experimental drug, RVU120, functions as a CDK8 kinase inhibitor and shows promise for development across hematological malignancies and solid tumors. This compound is presently in a Phase 1b clinical study for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Among their other assets is SEL24/MEN1703, a dual PIM/FLT3 kinase inhibitor licensed to the Menarini Group, which is currently undergoing a Phase 2 clinical trial for acute myeloid leukemia. Furthermore, Ryvu's earlier research pipeline explores candidates in areas such as kinases, cancer metabolism, synthetic lethality, and immuno-oncology. The company, established in 2007, is based in Kraków, Poland.
Show more...
CEO
Pawel Tadeusz Przewiezlikowski
Employees
228
Country
Poland
ISIN
PLSELVT00013
WKN
000A1JUH2
Listings
0 Comments
Share your thoughts
FAQ
What is Ryvu Therapeutics. stock price today?▼
The current price of RVU.WA is zł17.08 PLN — it has increased by +0.59% in the past 24 hours. Watch Ryvu Therapeutics. stock price performance more closely on the chart.
What is Ryvu Therapeutics. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Warsaw Stock Exchange exchange Ryvu Therapeutics. stocks are traded under the ticker RVU.WA.
Is Ryvu Therapeutics. stock price growing?▼
RVU.WA stock has fallen by -7.07% compared to the previous week, the month change is a +13.11% rise, over the last year Ryvu Therapeutics. has showed a -38.56% decrease.
What is Ryvu Therapeutics. market cap?▼
Today Ryvu Therapeutics. has the market capitalization of 394.89M
What is Ryvu Therapeutics. revenue for the last year?▼
Ryvu Therapeutics. revenue for the last year amounts to 62.25M PLN.
What is Ryvu Therapeutics. net income for the last year?▼
RVU.WA net income for the last year is -101.23M PLN.
How many employees does Ryvu Therapeutics. have?▼
As of September 04, 2026, the company has 228 employees.
In which sector is Ryvu Therapeutics. located?▼
Ryvu Therapeutics. operates in the Health & Wellness sector.
When did Ryvu Therapeutics. complete a stock split?▼
Ryvu Therapeutics. has not had any recent stock splits.
Where is Ryvu Therapeutics. headquartered?▼
Ryvu Therapeutics. is headquartered in Kraków, Poland.